Floatz logo

o6-benzylguanine

Childhood Central Nervous System Germ Cell Tumor

National Cancer Institute (NCI)Small moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Childhood Central Nervous System Germ Cell Tumor cohort.

Asset / SponsorPhaseRating
Eloxatin
National Cancer Institute (NCI)
Phase 2BB
Irinotecan
National Cancer Institute (NCI)
Phase 2BB
FILGRASTIM
City of Hope Medical Center
Phase 1CCC
Romidepsin
City of Hope Medical Center
Phase 1CCC
gw786034
National Cancer Institute (NCI)
Phase 1CC

View all 15 →

Same molecule, other indications

o6-benzylguanine is also rated in:

central nervous system neoplasmDormant
B
Indicative ·
60 / 100
View asset →
central nervous system cancerDormant
B
Indicative ·
60 / 100
View asset →
gliosarcomaDormant
B
Indicative ·
59 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →